Modulate Bio Inc.Amended

Biotechnology · ALLSTON, MA

BiotechnologySEC Form D

Modulate Bio Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 7, 2026, reporting $785,320 raised toward a $1,000,000 offering.

Incorporated in Delaware and based in ALLSTON, MA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Modulate Bio Inc. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Andrew ThomsonExecutive Officer · Director · Promoter
  • Dario DollerExecutive Officer · Director · Promoter
  • Kevin HodgettsPromoter

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$1.6MRaised

Biolexis Therapeutics Inc.

BiotechnologyLEHI, UT
May 20, 2026View SEC Form D
Modulate Bio Inc. raised $785.3K — SEC Form D